KELSIE OYER: Open Payments
NPI 1063906030 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 32 payments from 13 companies in 2025. Trend: 2023 $42 · 2024 $155 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 8 | $111 |
| Sage Therapeutics, LLC | 4 | $94 |
| Exeltis, USA Inc. | 4 | $67 |
| Sumitomo Pharma America, Inc. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| MILLICENT US INC | 2 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: NEXPLANON, ZURZUVAE, SLYND, MYFEMBREE, Lynkuet, Qelbree, Dexcom G6 Transmitter, FEMLYV.
Industry payments across OH — which companies pay providers there.
